US Stock MarketDetailed Quotes

INBX Inhibrx Biosciences

Watchlist
  • 14.080
  • +0.100+0.72%
Close Nov 22 16:00 ET
  • 15.400
  • +1.320+9.38%
Post 20:01 ET
203.82MMarket Cap0.12P/E (TTM)

Inhibrx Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
Total revenue
0
233.33%100K
0
25.60%1.63M
1.47M
119K
30K
0
1.3M
Operating revenue
--0
233.33%100K
--0
25.60%1.63M
--1.47M
--119K
--30K
--0
--1.3M
Cost of revenue
Gross profit
Operating expense
1.85%46.8M
289.18%161M
24.46%49.21M
32.37%154.38M
23.28M
45.95M
41.37M
39.54M
116.62M
Selling and administrative expenses
0.19%7.9M
1,185.50%93.37M
64.64%8.78M
61.28%24.25M
--2.7M
--7.89M
--7.26M
--5.33M
--15.04M
-General and administrative expense
0.19%7.9M
1,185.50%93.37M
64.64%8.78M
61.28%24.25M
--2.7M
--7.89M
--7.26M
--5.33M
--15.04M
Research and development costs
2.20%38.89M
98.30%67.63M
18.20%40.43M
28.08%130.13M
--20.58M
--38.06M
--34.11M
--34.21M
--101.6M
Other operating expenses
----
----
----
----
----
----
----
----
---14K
Operating profit
-2.12%-46.8M
-289.22%-160.9M
-24.46%-49.21M
-32.45%-152.75M
-21.82M
-45.83M
-41.34M
-39.54M
-115.32M
Net non-operating interest income expense
149.65%2.89M
52.29%-2.62M
-5.83M
-5.49M
Non-operating interest income
24.44%2.89M
13.55%2.74M
----
----
----
--2.32M
--2.41M
----
----
Non-operating interest expense
--0
-32.18%5.36M
----
----
----
--8.15M
--7.91M
----
----
Other net income (expense)
130.37%41K
931,681.11%2.02B
15.71%-59K
-58,100.00%-580K
-158K
-135K
-217K
-70K
1K
Special income (charges)
--0
--2.02B
----
----
----
--0
--0
----
----
-Less：Restructuring and merger&acquisition
--0
---2.02B
----
----
----
--0
--0
----
----
Other non- operating income (expenses)
130.37%41K
115.21%33K
15.71%-59K
-58,100.00%-580K
---158K
---135K
---217K
---70K
--1K
Income before tax
15.30%-43.86M
4,049.27%1.86B
-24.39%-49.27M
-32.96%-153.33M
-5.58M
-51.79M
-47.05M
-39.61M
-115.32M
Income tax
0
-60.00%2K
0.00%3K
-4K
2K
5K
3K
Earnings from equity interest net of tax
----
----
----
---1.63M
----
----
----
----
--0
Net income
15.30%-43.86M
4,048.85%1.86B
-24.39%-49.27M
-34.37%-154.96M
-7.21M
-51.79M
-47.05M
-39.61M
-115.33M
Net income continuous Operations
15.30%-43.86M
4,048.85%1.86B
-24.39%-49.27M
-34.37%-154.96M
---7.21M
---51.79M
---47.05M
---39.61M
---115.33M
Minority interest income
Net income attributable to the parent company
15.30%-43.86M
4,048.85%1.86B
-24.39%-49.27M
-34.37%-154.96M
-7.21M
-51.79M
-47.05M
-39.61M
-115.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
15.30%-43.86M
4,048.85%1.86B
-24.39%-49.27M
-34.37%-154.96M
-7.21M
-51.79M
-47.05M
-39.61M
-115.33M
Basic earnings per share
21.90%-2.84
3,946.92%127.1
-24.39%-3.4599
-34.37%-10.8814
-0.5061
-3.6366
-3.3039
-2.7814
-8.098
Diluted earnings per share
21.90%-2.84
3,897.89%125.48
-24.39%-3.4599
-34.37%-10.8814
-0.5061
-3.6366
-3.3039
-2.7814
-8.098
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022
Total revenue 0233.33%100K025.60%1.63M1.47M119K30K01.3M
Operating revenue --0233.33%100K--025.60%1.63M--1.47M--119K--30K--0--1.3M
Cost of revenue
Gross profit
Operating expense 1.85%46.8M289.18%161M24.46%49.21M32.37%154.38M23.28M45.95M41.37M39.54M116.62M
Selling and administrative expenses 0.19%7.9M1,185.50%93.37M64.64%8.78M61.28%24.25M--2.7M--7.89M--7.26M--5.33M--15.04M
-General and administrative expense 0.19%7.9M1,185.50%93.37M64.64%8.78M61.28%24.25M--2.7M--7.89M--7.26M--5.33M--15.04M
Research and development costs 2.20%38.89M98.30%67.63M18.20%40.43M28.08%130.13M--20.58M--38.06M--34.11M--34.21M--101.6M
Other operating expenses -----------------------------------14K
Operating profit -2.12%-46.8M-289.22%-160.9M-24.46%-49.21M-32.45%-152.75M-21.82M-45.83M-41.34M-39.54M-115.32M
Net non-operating interest income expense 149.65%2.89M52.29%-2.62M-5.83M-5.49M
Non-operating interest income 24.44%2.89M13.55%2.74M--------------2.32M--2.41M--------
Non-operating interest expense --0-32.18%5.36M--------------8.15M--7.91M--------
Other net income (expense) 130.37%41K931,681.11%2.02B15.71%-59K-58,100.00%-580K-158K-135K-217K-70K1K
Special income (charges) --0--2.02B--------------0--0--------
-Less：Restructuring and merger&acquisition --0---2.02B--------------0--0--------
Other non- operating income (expenses) 130.37%41K115.21%33K15.71%-59K-58,100.00%-580K---158K---135K---217K---70K--1K
Income before tax 15.30%-43.86M4,049.27%1.86B-24.39%-49.27M-32.96%-153.33M-5.58M-51.79M-47.05M-39.61M-115.32M
Income tax 0-60.00%2K0.00%3K-4K2K5K3K
Earnings from equity interest net of tax ---------------1.63M------------------0
Net income 15.30%-43.86M4,048.85%1.86B-24.39%-49.27M-34.37%-154.96M-7.21M-51.79M-47.05M-39.61M-115.33M
Net income continuous Operations 15.30%-43.86M4,048.85%1.86B-24.39%-49.27M-34.37%-154.96M---7.21M---51.79M---47.05M---39.61M---115.33M
Minority interest income
Net income attributable to the parent company 15.30%-43.86M4,048.85%1.86B-24.39%-49.27M-34.37%-154.96M-7.21M-51.79M-47.05M-39.61M-115.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 15.30%-43.86M4,048.85%1.86B-24.39%-49.27M-34.37%-154.96M-7.21M-51.79M-47.05M-39.61M-115.33M
Basic earnings per share 21.90%-2.843,946.92%127.1-24.39%-3.4599-34.37%-10.8814-0.5061-3.6366-3.3039-2.7814-8.098
Diluted earnings per share 21.90%-2.843,897.89%125.48-24.39%-3.4599-34.37%-10.8814-0.5061-3.6366-3.3039-2.7814-8.098
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data